ProCE Banner Activity

ExpressPoints
CAR T-Cell Therapy Guidance and Future Directions

Slideset Download
Download this short summary slideset of key takeaway points from a live presentation on key considerations for managed care and specialty pharmacy professionals in integrating CAR T-cell therapy into the care of patients with hematologic malignancies.

Released: August 11, 2021

Expiration: August 10, 2022

No longer available for credit.

Share

Faculty

Zahra Mahmoudjafari

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Clinical Pharmacy Manager, Blood and Marrow Transplant Program
Division of Hematological Malignancies and Cellular Therapeutics
PGY2 Oncology Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Clinical Pharmacy Manager, Blood and Marrow Transplant Program
Division of Hematological Malignancies and Cellular Therapeutics
PGY2 Oncology Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas